| Sources: NTRB Website. NTRB Presentation. -----
As mentioned above, NTRB has several potential catalysts that could create breakout buzz. Here's a few to consider now:
#1. NTRB Potential Catalyst - A $15 Analyst Target Suggests Substantial Upside Potential!
Back on June 20th, an analyst Noble Capital Markets suggested a new $15 target for NTRB.
From NTRB's closing valuation this past Tuesday, that target suggested over 85% potential upside.
Here's some key report highlights:
Conclusion. We had projected the NDA filing in late 2H25 to 1H2026 and valued the company based on discounted EPS from FY2027, the first full year of sales. Our EPS projections also allowed for a st-ock offering to raise capital in 1Q25, which was not necessary. In view of our conservative time line and lower-than-expected share base, we are raising our FY2027 EPS estimate to $1.57 per share with a 25% discount rate for a new price target of $15 per share. -----
#2. NTRB Potential Catalyst - A Low Float Could Create An Exceptionally Volatile Environment (Daily).
According to info from the Yahoo Finance website, NTRB has a pretty low float.
The website reports this profile to have roughly 4.42Mn shares in its float.
Why is that important? It's important on one crucial level. Volatility potential.
If positive company news appears in the midway part of 2025, could it provide a breakout spark? -----
#3. NTRB Potential Catalyst - Multiple Triggered Technical Indicators May Suggest A Positive Outlook And Trend Confirmation.
On Tuesday at 4:00PM EST, Barchart was reporting several triggered technical indicators across the short, medium, and long term for NTRB.
Here's their list (as of 4:00PM EST Tuesday):
Short Term Indicators
- 20 Day Moving Average
- 20 - 50 Day MA Crossover
- 20 - 100 Day MA Crossover
- 20 - 200 Day MA Crossover
Medium Term Indicators
- 50 Day Moving Average
- 50 - 100 Day MA Crossover
- 50 - 150 Day MA Crossover
- 50 - 200 Day MA Crossover
Long Term Indicators
- 100 Day Moving Average
- 150 Day Moving Average
- 200 Day Moving Average
- 100 - 200 Day MA Crossover
The website also shares its all-important "Trend Seeker" composite indicator is triggered as well.
Make sure to watch these technical indicators closely moving forward. -----
#4. NTRB Potential Catalyst - Nutriband And Kindeva Successfully Complete Commercial Manufacturing For AVERSA.
Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fent-a-nyl Abuse Deterrent Fent-a-nyl Patch
ORLANDO, Fla., June 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has completed commercial manufacturing process scale-up for its lead product, Aversa™ Fent-a-nyl, with Kindeva, a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products.
Nutriband is partnering with Kindeva to develop Aversa™ Fent-a-nyl which combines Nutriband’s Aversa™ abuse-deterrent technology with Kindeva’s FDA-approved fent-a-nyl patch. Aversa Fent-a-nyl is manufactured at Kindeva’s state-of-the-art transdermal manufacturing facility located in the United States. The next step is to manufacture clinical supplies and file an Investigational New Drug (IND) application with the FDA to initiate a human abuse liability clinical study.
“We are excited to achieve this commercial development milestone with our partner, Kindeva. Completing the commercial manufacturing scale-up is an important step towards development of a commercially viable product and eventual NDA filing. This achievement demonstrates the compatibility of the Aversa™ abuse deterrent platform technology with established transdermal patch manufacturing processes. Aversa Fent-a-nyl has the potential to be the first abuse deterrent pain patch on the market,” said Gareth Sheridan, CEO, Nutriband.
...
Read the full article here. -----
#5. NTRB Potential Catalyst - Nutriband Receives U.S. Patent Securing Key IP Protection.
Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology
Patent issuance expands United States patent coverage for AVERSA™ transdermal abuse deterrent technology
AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents issued in 46 countries including the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia.
ORLANDO, Fla., June 09, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that the United States Patent and Trademark Office (USPTO) issued patent number 12,318,492 on June 3, 2025, entitled "Abuse and Misuse Deterrent Transdermal Systems." The issuance of this patent further expands Nutriband’s intellectual property protection in the United States for its portfolio of abuse deterrent transdermal products based on its proprietary Aversa™ abuse deterrent technology. This technology can be incorporated into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential.
...
Read the full article here. -----
(Nasdaq: NTRB) Potential Catalyst Recap - The Top 5 To Consider Right Now
#1. A $15 Analyst Target Suggests Substantial Upside Potential!
#2. A Low Float Could Create An Exceptionally Volatile Environment (Daily).
#3. Multiple Triggered Technical Indicators May Suggest A Positive Outlook And Trend Confirmation.
#4. Nutriband And Kindeva Successfully Complete Commercial Manufacturing For AVERSA.
#5. Nutriband Receives U.S. Patent Securing Key IP Protection. -----
Coverage is officially reinitiated on Nutriband Inc. (Nasdaq: NTRB).
I'll be in touch with updates when necessary. Talk again soon.
Sincerely, FierceAnalyst | Jaks Swift Editorial Writer
(Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.)
*FierceInvestor (FierceInvestor . com) is owned by SWN Media LLC, a limited liability company. Data is provided from third-party sources and FierceInvestor ("FI") is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. We do not provide personalized fin-ancial advice, are not finan-cial advisors, and our opinions are not suitable for all in-vest-ors.
Pursuant to an agreement between SWN Media LLC and TD Media LLC, SWN Media LLC has been hired for a period beginning on 07/02/2025 and ending on 07/03/2025 to publicly disseminate information about (NTRB:US) via digital communications. Under this agreement, SWN Media LLC has been paid seventeen thousand five hundred USD ("Funds"). To date, including under the previously described agreement, SWN Media LLC has been paid one hundred forty five thousand USD ("Funds"). These Funds were part of the funds that TD Media LLC received from Nutriband Inc., the issuer of (NTRB:US).
Neither SWN Media LLC, TD Media LLC and their member own shares of (NTRB:US).
Please see important disclosure information here: https://fierceinvestor.com/disclosure/ntrb-kfqwn/#details | 
No comments:
Post a Comment